TRIUMPH-3: Weight management in people with cardiovascular disease Additional TRIUMPH Trials: Type 2 diabetes management Chronic low back pain Metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH/NAFLD) Cardiovascular and renal outcomes The TRIUMPH program has enrolled more than 5,800 participants total, making it one of the largest Phase 3 programs for an obesity medication in history
Sip water through the day instead of drinking large amounts all at once
Typical costs range from $150-300 CAD for a multi-week supply
Her request for coverage had been denied, the letter said, because she'd had a body mass index of less than 35 when she started Zepbound
These GLP-1 medications are commonly prescribed for weight management and have been shown to greatly accelerate and improve weight loss, with the majority of Ozempic clinical trial participants losing between 5-10% of their body weight
Three body areas provide reliable subcutaneous access for most people